![]() |
|||||||||||||||||||||
![]() |
CLINICAL TRIALS NETWORK NIDA-CTN-0019 Principal Investigator:
Women in drug-using
communities are one of the fastest growing groups of people with AIDS
in the U.S. Female drug users, even if they are in drug treatment, are
at especially high risk for heterosexual transmission of HIV. First, they
are often in primary sexual relationships with male drug users. Second,
like their male peers, despite treatment, some continue to use drugs.
Under the influence of drugs, especially cocaine or crack, they are more
likely to engage in unprotected sex. It has been shown that drug abuse
treatment can reduce activities related to drug use that increase the
risk of getting or transmitting HIV. These behaviors have received less
attention, however, than those directly related to drug use. This study
looks at a program for women in drug abuse treatment designed to build
safer sexual skills and reduce unprotected sexual risk behavior. The program
includes five sessions of group treatment that focus on assessing HIV
risk, HIV safer sex problem-solving, condom use, negotiation, and assertiveness
training. This program will be compared to one session of HIV/STD education,
which is typically provided as standard in drug treatment clinics. |
||||||||||||||||||||
![]() |
|||||||||||||||||||||
![]() |
|||||||||||||||||||||